货号:A240443
同义名:
20(S)-人参皂苷 Rg3;人参皂苷 Rg3
/ S-ginsenoside Rg3; Ginsenoside Rg3
20(S)-Ginsenoside Rg3是一种类固醇糖苷衍生物,能够影响主动脉内皮的舒张作用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Sodium Channel ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolperisone HCl | ✔ | 99% | |||||||||||||||||
| Triamterene |
+++
ENaC, IC50: 4.5 μM |
98% | |||||||||||||||||
| Lamotrigine | ✔ | 98% | |||||||||||||||||
| Vinpocetine | ✔ | 98% | |||||||||||||||||
| Zonisamide | ✔ | 99% | |||||||||||||||||
| Dronedarone HCl | ✔ | 95% | |||||||||||||||||
| Procainamide HCl | ✔ | 99% | |||||||||||||||||
| Bupivacaine HCl | ✔ | 99+% | |||||||||||||||||
| Benzocaine | ✔ | 98% | |||||||||||||||||
| Carbamazepine |
++
Sodium channel, IC50: 131 μM |
98% | |||||||||||||||||
| Quinidine sulfate dihydrate | ✔ | 98% | |||||||||||||||||
| Ibutilide fumarate | ✔ | 99%+ | |||||||||||||||||
| Dibucaine HCl | ✔ | 99+% | |||||||||||||||||
| Mexiletine HCl | ✔ | 99% | |||||||||||||||||
| Phenytoin | ✔ | 99+% | |||||||||||||||||
| Camostat Mesylate |
+++
epithelial sodium channel (ENaC), IC50: 50 nM |
99%+ | |||||||||||||||||
| Levobupivacaine | ✔ | 97+% | |||||||||||||||||
| Oxcarbazepine |
+
sodium channel, IC50: 160 μM |
98% | |||||||||||||||||
| Amiloride HCl dihydrate | ✔ | 97% | |||||||||||||||||
| Ambroxol | 98+% | ||||||||||||||||||
| Primidone | ✔ | 99% | |||||||||||||||||
| Propafenone | ✔ | 99% | |||||||||||||||||
| A-803467 |
++++
Na(V1.8) channel, IC50: 8 nM |
99%+ | |||||||||||||||||
| Rufinamide | ✔ | 99% | |||||||||||||||||
| Phenytoin sodium | ✔ | 98% | |||||||||||||||||
| Proparacaine HCl |
+
Voltage-gated sodium channel, ED50: 3.4 mM |
98+% | |||||||||||||||||
| Amiloride HCl | ✔ | 98% | |||||||||||||||||
| Riluzole | ✔ | 97% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | Ginsenoside Rg3, a naturally occurring phytochemical, plays an important role in the induction of apoptosis, and the inhibition of proliferation, metastasis and angiogenesis, as well as the promotion of immunity[3]. Ginsenoside Rg3 (Rg3) is one of the key components of a frequently used herbal tonic panax ginseng for fatigue treatment. In the open field test, Rg3 significantly increased the journey distance and rearing frequency, while slowed down the rest time. Rg3 could improve exercise performance and resist fatigue possibly through elevating SIRT1 (silent information regulator of transcription 1) deacetylase activity[4]. Ginsenoside Rg3 could attenuate (lipopolysaccharide) LPS-induced ALI (Acute lung injury) by decreasing the levels of pro-inflammatory mediators and increasing the production of anti-inflammatory cytokines[5]. Moreover, ginsenoside Rg3 suppresses angiogenesis in developing endometrial lesions. The ginsenoside Rg3 inhibitory effect on the growth of the ectopic endometrium in EMs rats might occur through the blocking of the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway, thus halting angiogenesis and promoting the apoptosis of ectopic endometrial cells[6]. |
| Concentration | Treated Time | Description | References | |
| primary cardiac fibroblasts (CFs) | 5, 10, 20 μM | 48 h | To investigate the inhibitory effect of Rg3 on TGF-β1-induced CFs proliferation, results showed that Rg3 dose-dependently inhibited CFs proliferation. | J Ginseng Res. 2023 Nov;47(6):743-754 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL/6 mice | LAD coronary artery ligation-induced MI model | Intragastric administration | 20 mg/kg, 40 mg/kg | Once daily for 4 weeks | To investigate the protective effect of Rg3 on myocardial fibrosis and cardiac function, results showed that Rg3 dose-dependently improved cardiac function and inhibited collagen deposition. | J Ginseng Res. 2023 Nov;47(6):743-754 |
| Wistar rats | Alcohol GU model, pylorus-ligated GU model, acetic acid GU model | Intragastric administration | 20 mg/kg | Once daily for 7 days | To evaluate the treatment efficacy of 20(S)-ginsenoside Rg3 on gastric ulcer. The results showed that 20(S)-ginsenoside Rg3 significantly decreased the UI scores and UI ratios in all three GU models, and demonstrated antiulcer effects by decreasing ET-1 and NOS2 levels and increasing NO, superoxide dismutase, EGF, and epidermal growth factor receptor levels. In addition, high-dose 20(S)-ginsenoside Rg3 showed satisfactory gastric mucosa protection effects. | J Ginseng Res. 2019 Oct;43(4):550-561 |
| BALB/c mice | Lethal HVJ infection model | Oral | 1 mg/mouse | Once daily for 3, 2, and 1 day before infection | 20(S)-Ginsenoside Rg3 showed partial protection against HVJ infection | J Ginseng Res. 2013 Mar;37(1):80-6 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.27mL 0.25mL 0.13mL |
6.37mL 1.27mL 0.64mL |
12.74mL 2.55mL 1.27mL |
|
| CAS号 | 14197-60-5 |
| 分子式 | C42H72O13 |
| 分子量 | 785.01 |
| SMILES Code | O[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@@H]3C(C)([C@]4([C@@](C)([C@@]5([H])C[C@@H](O)[C@@]([C@H](CC6)[C@@](CC/C=C(C)\C)(C)O)([H])[C@]6(C)[C@]5(C)CC4)CC3)[H])C)CO)O)O)CO)O)O |
| MDL No. | MFCD06410950 |
| 别名 | 20(S)-人参皂苷 Rg3;人参皂苷 Rg3;人参皂甙 Rg3 ;S-ginsenoside Rg3; Ginsenoside Rg3; VN10040; 20S-Ginsenoside Rg3; 20(S)-Propanaxadiol |
| 运输 | 蓝冰 |
| InChI Key | RWXIFXNRCLMQCD-JBVRGBGGSA-N |
| Pubchem ID | 9918693 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(133.76 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1